Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001829126-25-009159
Filing Date
2025-11-14
Accepted
2025-11-14 10:33:52
Documents
55
Period of Report
2025-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q nexalintechno_10q.htm   iXBRL 10-Q 927805
2 EXHIBIT 31.1 nexalintechno_ex31-1.htm EX-31.1 13049
3 EXHIBIT 31.2 nexalintechno_ex31-2.htm EX-31.2 13068
4 EXHIBIT 32.1 nexalintechno_ex32-1.htm EX-32.1 5819
5 EXHIBIT 32.2 nexalintechno_ex32-2.htm EX-32.2 5877
  Complete submission text file 0001829126-25-009159.txt   4688905

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE nxl-20250930.xsd EX-101.SCH 32322
7 XBRL CALCULATION FILE nxl-20250930_cal.xml EX-101.CAL 43803
8 XBRL DEFINITION FILE nxl-20250930_def.xml EX-101.DEF 124990
9 XBRL LABEL FILE nxl-20250930_lab.xml EX-101.LAB 244372
10 XBRL PRESENTATION FILE nxl-20250930_pre.xml EX-101.PRE 210124
57 EXTRACTED XBRL INSTANCE DOCUMENT nexalintechno_10q_htm.xml XML 761447
Mailing Address 1776 YORKTOWN SUITE 550 HOUSTON TX 77056
Business Address 1776 YORKTOWN SUITE 550 HOUSTON TX 77056 (832) 260-0222
Nexalin Technology, Inc. (Filer) CIK: 0001527352 (see all company filings)

EIN.: 275566468 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41507 | Film No.: 251482420
SIC: 3845 Electromedical & Electrotherapeutic Apparatus
(CF Office: 08 Industrial Applications and Services)